Patterns of Care and Survival of Chinese Glioblastoma Patients in the Temozolomide Era: A Hong Kong Population-Level Analysis over a 14-year Period - HKNOS
Skip to content
HKNOS
The Hong Kong Neuro-Oncology Society
Home
Members/Healthcare professionals
objectives / council members / memberships / contact us
Education Centre
中
© 2023 The hong kong neuro-oncology society. all rights reserved.
HKNOS
The Hong Kong Neuro-Oncology Society
DONATIONS
中

Patterns of Care and Survival of Chinese Glioblastoma Patients in the Temozolomide Era: A Hong Kong Population-Level Analysis over a 14-year Period

Post navigation

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study

Recent Posts

  • 腦腫瘤關注月 Brain Tumor Awareness Month
  • Events outside HKNOS: ASNO-SNO Clinical Trials Workshop January 2023
  • Events outside HKNOS: Evolving Treatment Paradigm in Stereotactic Radiosurgery for Brain Metastasis
  • Events outside HKNOS: Uncovering NF1 Plexiform Neurofibromas – MDT Approach in Diagnosis and Management
  • HKNOS December 2022 AGM & Symposium

Categories

  • Event
  • Events outside HKNOS
  • General Public
  • Uncategorized
The Hong Kong Neuro-Oncology Society
香港神經腫瘤學會